Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial.

Saved in:
Bibliographic Details
Title: Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial.
Authors: Samuels AM; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, United States Centers for Disease Control and Prevention, Kisumu, Kenya; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: amsamuels@cdc.gov., Ansong D; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Kariuki SK; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Adjei S; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Bollaerts A; GSK, Wavre, Belgium., Ockenhouse C; PATH's Malaria Vaccine Initiative, Washington, DC, USA., Westercamp N; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA., Lee CK; PATH's Malaria Vaccine Initiative, Washington, DC, USA., Schuerman L; GSK, Wavre, Belgium., Bii DK; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Osei-Tutu L; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Oneko M; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Lievens M; GSK, Wavre, Belgium., Attobrah Sarfo MA; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Atieno C; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Morelle D; GSK, Wavre, Belgium., Bakari A; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Sang T; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Jongert E; GSK, Wavre, Belgium., Kotoh-Mortty MF; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Otieno K; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Roman F; GSK, Wavre, Belgium., Buabeng PBY; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Ntiamoah Y; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Ofori-Anyinam O; GSK, Wavre, Belgium., Agbenyega T; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
Corporate Authors: RTS,S study group
Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Sep; Vol. 22 (9), pp. 1329-1342. Date of Electronic Publication: 2022 Jun 23.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-4457
DOI:10.1016/S1473-3099(22)00273-0